WeVote

Bill

Bill

SB 29

Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.

2025 Regular Session Introduced by Warren Hamilton

Oklahoma bill requiring health practitioners to offer genetic testing before prescribing psychiatric medications to optimize drug selection and reduce adverse effects.

Second Reading referred to Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 29

Legislative bill overview

SB 29 would require Oklahoma licensed health care practitioners to offer pharmacogenomic testing to patients before prescribing psychotropic medications. Pharmacogenomic tests analyze how a patient's genetics affect drug metabolism and response. The bill establishes a new standard of care for psychiatric medication prescribing in the state.

Why is this important

Psychotropic drugs (antidepressants, antipsychotics, anti-anxiety medications) affect millions of Oklahomans, but individuals metabolize them differently based on genetic factors. Pharmacogenomic testing can theoretically reduce adverse effects, improve treatment outcomes, and lower healthcare costs by identifying which medications will work best for each patient. However, this represents a significant change to current prescribing practices and has cost implications for patients and providers.

Potential points of contention

  • Cost and access: Pharmacogenomic tests typically cost $100-$3,000+ and insurance coverage varies; requiring the offer (not necessarily payment) could create barriers for uninsured/underinsured patients or shift costs to providers
  • Clinical evidence debate: While some studies support pharmacogenomic testing, major medical organizations have mixed guidance on routine implementation; mandating offers may overstate the evidence strength
  • Provider burden: The requirement to "offer" testing adds administrative and documentation requirements; practitioners may face liability questions if they don't offer or if patients decline

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.